Stephan Windecker Selected Research

Atherosclerosis

1/2021	Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines.
7/2019	Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.
1/2018	Long-Term Assessment of Bioresorbable Coronary Scaffolds: Disappearing Stents, Reappearing Atherosclerosis.
11/2017	Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
8/2015	The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
2/2015	Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Windecker Research Topics

Disease

214	Thrombosis (Thrombus) 04/2024 - 03/2002
192	Myocardial Infarction 05/2024 - 11/2002
135	Hemorrhage 05/2024 - 10/2007
111	Acute Coronary Syndrome 01/2024 - 11/2005
98	ST Elevation Myocardial Infarction 01/2024 - 10/2007
94	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 12/2002
86	Aortic Valve Stenosis (Aortic Stenosis) 04/2024 - 11/2009
75	Stroke (Strokes) 04/2024 - 05/2008
67	Death (Near-Death Experience) 01/2024 - 11/2002
66	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 11/2002
30	Atrial Fibrillation 04/2024 - 11/2003
22	Heart Failure 02/2024 - 04/2003
20	Infarction (Infarctions) 05/2024 - 05/2005
19	Pathologic Constriction (Stenosis) 07/2023 - 05/2005
18	Cardiogenic Shock 10/2021 - 09/2005
17	Atherosclerotic Plaque (Atheroma) 10/2023 - 07/2011
15	Diabetes Mellitus 08/2023 - 08/2008
14	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2023 - 02/2015
13	Inflammation (Inflammations) 11/2022 - 12/2002
12	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 01/2007
11	Patent Foramen Ovale 01/2021 - 06/2004
11	Hyperplasia 01/2020 - 01/2003
10	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2022 - 10/2014
10	Ischemia 11/2021 - 01/2007
10	Hypertension (High Blood Pressure) 05/2021 - 07/2011
9	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 03/2024 - 04/2015
9	Renal Insufficiency (Renal Failure) 12/2021 - 04/2015
9	Neointima 12/2018 - 12/2011
8	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 12/2015
7	Neoplasms (Cancer) 04/2024 - 05/2015
7	Heart Diseases (Heart Disease) 10/2023 - 06/2015
7	Transient Ischemic Attack 01/2022 - 02/2009
6	AIDS-Related Complex (ARC) 01/2022 - 01/2019
6	Atherosclerosis 01/2021 - 02/2015
5	Frailty 02/2024 - 05/2012
5	Chronic Renal Insufficiency 08/2023 - 01/2016
5	Non-ST Elevated Myocardial Infarction 01/2021 - 10/2011
5	Ischemic Stroke 09/2020 - 05/2008
5	Paradoxical Embolism 07/2014 - 02/2009
4	Peripheral Vascular Diseases (Peripheral Vascular Disease) 11/2023 - 11/2012
4	COVID-19 10/2023 - 09/2020
4	Peripheral Arterial Disease 10/2021 - 10/2016
4	Left Ventricular Dysfunction 10/2021 - 09/2008
4	Coronary Occlusion 03/2021 - 01/2003
4	Pulmonary Embolism 09/2020 - 04/2003

Drug/Important Bio-Agent (IBA)

57	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 08/2014
57	omega-Chloroacetophenone (Mace)IBA 11/2023 - 11/2002
45	Everolimus FDA Link 01/2024 - 07/2010
44	PolymersIBA 11/2023 - 09/2006
37	Sirolimus (Rapamycin)FDA Link 11/2023 - 01/2003
33	TicagrelorIBA 03/2024 - 11/2014
32	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 02/2007
31	MetalsIBA 11/2022 - 06/2005
22	Clopidogrel (Plavix)FDA Link 03/2024 - 02/2007
19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 02/2015
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2008
16	LipidsIBA 10/2023 - 03/2015
15	zotarolimusIBA 01/2022 - 08/2009
14	BESIBA 01/2023 - 09/2009
14	CreatinineIBA 01/2022 - 01/2014
13	AnticoagulantsIBA 11/2023 - 05/2016
13	Prasugrel Hydrochloride FDA Link 01/2021 - 11/2014
13	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 08/2005
12	bivalirudin (Angiomax)FDA Link 12/2021 - 12/2015
10	Hemoglobins (Hemoglobin)IBA 11/2022 - 09/2005
10	Vitamin K FDA Link 01/2022 - 01/2013
10	LDL CholesterolIBA 01/2021 - 09/2015
9	apixabanIBA 01/2022 - 01/2018
9	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 12/2015
8	oxidized low density lipoproteinIBA 01/2022 - 01/2017
8	TroponinIBA 01/2022 - 12/2008
8	C-Reactive ProteinIBA 10/2021 - 02/2016
7	Troponin T (Troponin T1)IBA 10/2021 - 04/2003
6	alirocumabIBA 03/2024 - 01/2021
6	evolocumabIBA 01/2023 - 01/2017
6	thienopyridineIBA 02/2016 - 03/2015
5	SubtilisinIBA 03/2024 - 11/2017
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 01/2013
5	RivaroxabanIBA 10/2023 - 02/2017
5	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 04/2003
5	Phenobarbital (Luminal)FDA Link 11/2015 - 10/2012
5	chemotactic factor inactivatorIBA 01/2007 - 11/2002
4	Prealbumin (Transthyretin)IBA 12/2023 - 01/2015
4	Proprotein Convertase 9IBA 09/2023 - 01/2018
4	pro-brain natriuretic peptide (1-76)IBA 10/2021 - 03/2018

Therapy/Procedure

271	Stents 04/2024 - 03/2002
182	Percutaneous Coronary Intervention 05/2024 - 05/2005
137	Therapeutics 04/2024 - 06/2005
120	Transcatheter Aortic Valve Replacement 04/2024 - 11/2009
83	Drug-Eluting Stents 04/2024 - 02/2007
15	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2024 - 03/2010
14	Bioprosthesis 01/2023 - 05/2012
13	Secondary Prevention 01/2024 - 02/2008
12	Patient Readmission 01/2020 - 10/2007
11	Duration of Therapy 01/2023 - 03/2015
10	Prostheses and Implants (Prosthesis) 05/2023 - 04/2010
7	Cardiac Rehabilitation 01/2023 - 10/2013
6	Catheters 09/2020 - 09/2005
6	Myocardial Revascularization 01/2019 - 07/2011
5	Septal Occluder Device 01/2021 - 03/2015